[ET Net News Agency, 10 March 2026] SKB BIO-B (06990) rose 9.3% to HK$415.2.
It hits an intra-day high of HK$418, breaking above the 250-D SMA of HK$394.217, and an intra-day low of HK$394.8. The total shares traded was 204,447, with a value of HK$83.35m. The active buy/sell ratio is 73:27, with net buying turnover of HK$33.85m. CLSA LTD accounts for greatest net responsive buying turnover of HK$4.97m, with volume weighted average price of HK$407.403. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$15.39m, with volume weighted average price of HK$407.784.
Basic Information| Nominal | 415.200 | % Chg | +9.26% |
| High | 418.000 | Low | 394.800 |
| Shares Tr | 204,447 | Turnover | 83.35m |
| 10-D SMA | 379.700 | %H.V | 47.899 |
| 20-D SMA | 400.420 | VWAP | 407.678 |
| 50-D SMA | 420.112 | RSI14 | 54.455 |
Status: Breaking above the 250-D SMA, active buy/sell ratio is 73:27, with net buying turnover of HK$33.85m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SKB BIO-B (06990) | 415.20 | +9.26 |
| INNOVENT BIO (01801) | 84.95 | +3.91 |
| CARSGEN-B (02171) | 15.02 | +7.90 |
| XTALPI (02228) | 9.99 | +2.57 |
| WUXI BIO (02269) | 36.48 | +2.99 |
| WUXI APPTEC (02359) | 111.60 | +2.57 |
| TRANSTHERA-B (02617) | 86.60 | +1.23 |
| BEONE MEDICINES (06160) | 183.90 | +2.79 |
| AKESO (09926) | 112.10 | +8.10 |
| REMEGEN (09995) | 87.65 | +2.69 |
(ed)
Nominal 